SYNCOM

Members of the Exchange are hereby informed that trading in equity shares of Syncom Healthcare Limited (ISIN: INE602K01014) shall be suspended w.e.f. June 29, 2021 pursuant to order dated June 14, 2021 passed by National Company Law Tribunal.

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 11-Sep-2019, regarding��Intimation to stock Exchange under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. 2015.��On basis of above the Company is required to clarify following: 1. Quantum of claims, if any 2. Expected financial implications, if any, due to compensation, penalty etc; 3. Brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is filed, brief details of

SYNCOM:The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 30-May-2019, regarding�� Board meeting held on May 30, 2019.".On basis of above the Company is required to clarify following:1. Disclosure�� of�� relationships�� between�� directors�� (in�� case�� of�� appointment�� of�� a director)<br>The response of the Company is enclosed.

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 30-May-2019, regarding " Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on May 30, 2019.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director)<br> The response of the Company is awaited.

SYNCOM: The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 31-Jan-2019, regarding Appointment of Mr Manoj Negi as Executive Director-Technical of the company w.e.f. January 31, 2019.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director)The response of the Company is attached.

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 31-Jan-2019, regarding Appointment of Mr Manoj Negi as Executive Director-Technical of the company w.e.f. January 31, 2019.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director)The response of the Company is awaited.

The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 16-Jan-2018, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is attached.

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 16-Jan-2018, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.

SYNCOM:The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 13-Oct-2017, regarding " Syncom Healthcare Limited has informed the Exchange regarding 'MATERIAL EVENTS UNDER REGULATION 30 OF THE LISTING REGULATIONS '.". On basis of above the Company is required to clarify following: 1. Subsequently, the listed entity shall inform the stock exchange(s), the actual impact (monetary or otherwise) along with corrective actions taken by the listed entity pursuant to the withdrawal, cancellation or suspension of the key license/ approval.2. Period for w

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 13-Oct-2017, regarding " Syncom Healthcare Limited has informed the Exchange regarding 'MATERIAL EVENTS UNDER REGULATION 30 OF THE LISTING REGULATIONS '.". On basis of above the Company is required to clarify following: 1. Subsequently, the listed entity shall inform the stock exchange(s), the actual impact (monetary or otherwise) along with corrective actions taken by the listed entity pursuant to the withdrawal, cancellation or suspension of the key license/ approval.2. Period for w

The Exchange had sought clarification from Syncom Healthcare Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: 1. Adoption of Ind AS for the quarter ended June 30, 2017. 2. Segment Reporting not given 3. Reconciliation of Profit & loss not given 4. The unaudited profit & loss Account is submitted whereas the Auditors Report states that the quarterly and year to date results have been audited. 5. The corrigendum submitted states that the

The Exchange has sought clarification from Syncom Healthcare Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: 1. Adoption of Ind AS for the quarter ended June 30, 2017. 2. Segment Reporting not given 3. Reconciliation of Profit & loss not given 4. The unaudited profit & loss Account is submitted whereas the Auditors Report states that the quarterly and year to date results have been audited. 5. The corrigendum submitted states that the

SYNCOM: The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 24-Jan-2017, informing that Mrs. Charu Srivastava having M. No. 27108 has been appointed as Company Secretary cum Compliance Officer of the Company with effect from 24th January 2017.On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment);The response of the Company is as follows:Charu Srivastava , ACS (M. No. A27108) and LLB has been appointed as a Company Secretary cum Compliance Officer of the Syncom Healthcare Limited. She has a fo

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 24-Jan-2017, informing that Mrs. Charu Srivastava having M. No. 27108 has been appointed as Company Secretary cum Compliance Officer of the Company with effect from 24th January 2017.On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment);The response of the Company is awaited.

SYNCOM: The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 02-Jan-2017, regarding "Syncom Healthcare Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on December 31, 2016.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); 2. Disclosure of relationships between directors (in case of appointment of a director). The response of the Company is attached.

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 02-Jan-2017, regarding "Syncom Healthcare Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on December 31, 2016.".On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment);2. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.

The Exchange had sought clarification from Syncom Healthcare Limited with respect to Complaint received by the Exchange in regard to default made by Shri Ajay Shankarlal Bankda (Managing Director) under the Negotiable Instruments Act. The Company vide letter dated April 19, 2016 has provided Shri Ajay Shankarlal Bankda's response which states that the Complaints filed are borne out of disputes arising due to personal transactions; the matter is being represented by Shri Ajay Shankarlal Bankda's advocate in the relevant court. None of the matters are linked with the Company in any way and are i